This company seems to have been delisted
Reason: Filed for bankruptcy
Source: https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/biolase-voluntarily-initiates-chapter-11-proceedings-926432
Reason: Filed for bankruptcy
Source: https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/biolase-voluntarily-initiates-chapter-11-proceedings-926432
Biolase
BIOL
A$0.01831
Share price
0.00%
Change (1 day)
-92.73%
Change (1 year)
Categories
Biolase (BIOL) - Total debt
Total debt on the balance sheet as of September 2024 : A$28.51 Million
According to Biolase 's latest financial reports the company's total debt is A$28.51 Million. A company’s total debt is the sum of all current and non-current debts.
Biolase - Total debt on balance sheet (from 1997 to 2024)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | A$23.05 M | 8.13% |
| 2021-12-31 | A$21.32 M | -10.24% |
| 2020-12-31 | A$23.75 M | 20.58% |
| 2019-12-31 | A$19.7 M | 28.08% |
| 2018-12-31 | A$15.38 M | |
| 2017-12-31 | N/A | -100% |
| 2016-12-31 | A$0.22 M | -50.71% |
| 2015-12-31 | A$0.44 M | |
| 2013-12-31 | A$5.19 M | 229.73% |
| 2012-12-31 | A$1.57 M | |
| 2010-12-31 | A$2.58 M | |
| 2008-12-31 | A$7.65 M | 88.53% |
| 2007-12-31 | A$4.06 M | |
| 2005-12-31 | A$6.83 M | |
| 2003-12-31 | A$3.6 M | -39% |
| 2002-12-31 | A$5.91 M | 68.33% |
| 2001-12-31 | A$3.51 M | -34.27% |
| 2000-12-31 | A$5.34 M | 161.61% |
| 1999-12-31 | A$2.04 M | -26.45% |
| 1998-12-31 | A$2.77 M | 502.95% |
| 1997-12-31 | A$0.46 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 Align Technology
ALGN | A$0.18 B | 534.22% | 🇺🇸 USA |
 Dentsply Sirona
XRAY | A$3.69 B | 12,864.15% | 🇺🇸 USA |